EarningsQ3 2024 Earnings Report

Dermapharm Holding SE (DMPHF) Q3 2024 Earnings Report

0 Followers

DMPHF Q3 2024 EPS Results

Actual EPS$0.67

Consensus EPS―

Beat/Miss―

One Year Ago EPS$0.52

Actual Revenue$349.17M

Expected Revenue$332.02M

Beat/MissBeat by +$17.15M

YoY Revenue Growth+9.54%

QuarterQ3 2024

Date11/14/2024

TimeBefore Open

Conference CallThursday, November 14, 2024

DMPHF Upcoming Earnings

Dermapharm Holding SE's next earnings date is estimated for November 12, 2026, based on past reporting schedules.

No earnings call audio is available for this earnings event.

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 12, 2026	2026 (Q3)	- / -	0.852	―
Aug 25, 2026	2026 (Q2)	0.53 / 0.53	0.437	20.51% (+0.09)
May 13, 2026	2026 (Q1)	- / 0.94	0.695	35.48% (+0.25)
Mar 10, 2026	2025 (Q4)	0.46 / 0.81	0.426	89.47% (+0.38)
Nov 13, 2025	2025 (Q3)	- / 0.85	0.672	26.67% (+0.18)
Aug 26, 2025	2025 (Q2)	- / 0.44	0.359	21.88% (+0.08)
May 15, 2025	2025 (Q1)	- / 0.69	0.908	-23.46% (-0.21)
Mar 14, 2025	2024 (Q4)	- / 0.43	-0.056	860.00% (+0.48)
Nov 14, 2024	2024 (Q3)	- / 0.67	0.515	30.43% (+0.16)
Aug 27, 2024	2024 (Q2)	- / 0.36	-0.19	288.24% (+0.55)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed